CGA

glycoprotein hormones, alpha polypeptide, the group of Receptor ligands|Glycoprotein hormone subunits

Basic information

Region (hg38): 6:87085498-87095106

Links

ENSG00000135346NCBI:1081OMIM:118850HGNC:1885Uniprot:P01215AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the CGA gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the CGA gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
1
clinvar
2
missense
0
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
1
1
non coding
0
Total 0 0 0 1 1

Variants in CGA

This is a list of pathogenic ClinVar variants found in the CGA region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
6-87085839-G-A Benign (Jul 30, 2018)714315
6-87086295-G-A Benign (May 15, 2018)736145
6-87086328-T-C Likely benign (May 11, 2018)742220

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
CGAprotein_codingprotein_codingENST00000369582 39609
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.3450.603117574011175750.00000425
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.503063.70.4710.00000333754
Missense in Polyphen931.4570.28611389
Synonymous0.09782727.70.9760.00000187218
Loss of Function1.5214.470.2241.87e-764

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.000.00
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.000.00
European (Non-Finnish)0.000009390.00000939
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Shared alpha chain of the active heterodimeric glycoprotein hormones thyrotropin/thyroid stimulating hormone/TSH, lutropin/luteinizing hormone/LH, follitropin/follicle stimulating hormone/FSH and choriogonadotropin/CG. These hormones bind specific receptors on target cells that in turn activate downstream signaling pathways. {ECO:0000269|PubMed:24692546, ECO:0000269|PubMed:2494176}.;
Pathway
Regulation of lipolysis in adipocytes - Homo sapiens (human);Thyroid hormone synthesis - Homo sapiens (human);Autoimmune thyroid disease - Homo sapiens (human);GnRH signaling pathway - Homo sapiens (human);Prolactin signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Ovarian steroidogenesis - Homo sapiens (human);Intracellular Signalling Through LHCGR Receptor and Luteinizing Hormone/Choriogonadotropin;Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone;Thyroxine (Thyroid Hormone) Production;Human Thyroid Stimulating Hormone (TSH) signaling pathway;Follicle Stimulating Hormone (FSH) signaling pathway;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;Signaling by GPCR;Signal Transduction;Gene expression (Transcription);Peptide hormone metabolism;Generic Transcription Pathway;Metabolism of lipids;Post-translational protein modification;Reactions specific to the complex N-glycan synthesis pathway;N-glycan antennae elongation in the medial/trans-Golgi;Metabolism of proteins;GPCR signaling-G alpha q;Metabolism of amino acids and derivatives;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;RNA Polymerase II Transcription;Metabolism;G alpha (s) signalling events;Mineralocorticoid biosynthesis;Hormone ligand-binding receptors;Androgen biosynthesis;Metabolism of steroid hormones;Metabolism of steroids;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Glucocorticoid receptor regulatory network;TFAP2 (AP-2) family regulates transcription of growth factors and their receptors;Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors;GPCR signaling-G alpha i;TSH;Thyroxine biosynthesis;Amine-derived hormones;Glycoprotein hormones;GPCR downstream signalling;Steroid hormones;Peptide hormone biosynthesis;FSH (Consensus)

Recessive Scores

pRec
0.405

Intolerance Scores

loftool
0.187
rvis_EVS
-0.05
rvis_percentile_EVS
49.39

Haploinsufficiency Scores

pHI
0.00193
hipred
N
hipred_score
0.286
ghis
0.497

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0338

Mouse Genome Informatics

Gene name
Cga
Phenotype
homeostasis/metabolism phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); reproductive system phenotype;

Zebrafish Information Network

Gene name
cga
Affected structure
head
Phenotype tag
abnormal
Phenotype quality
orientation

Gene ontology

Biological process
regulation of transcription by RNA polymerase II;G protein-coupled receptor signaling pathway;positive regulation of cell population proliferation;regulation of signaling receptor activity;positive regulation of steroid biosynthetic process;peptide hormone processing;positive regulation of cell migration;positive regulation of transcription by RNA polymerase II
Cellular component
extracellular region;extracellular space;Golgi lumen;follicle-stimulating hormone complex
Molecular function
hormone activity;protein binding;follicle-stimulating hormone activity